{"filing":{"accession_number":"0001193125-26-340271","cik":"0001658678","ticker":"BSEM","company_name":"BioStem Technologies, Inc.","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-06","primary_document":"bsem-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1658678/000119312526340271/bsem-20260806.htm"},"events":[{"id":25045,"run_id":22719,"accession_number":"0001193125-26-340271","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"BioStem announced its uplisting from the OTC Basic Market to The Nasdaq Capital Market, effective August 7, 2026, with trading commencing under ticker \"BSEM.\" This is a material operational and strategic milestone that improves market visibility, liquidity, and access to capital for the company and its shareholders. While not a traditional M\u0026A transaction or governance change, the uplisting is a significant corporate event that would affect a reasonable investor's assessment of the registrant's market position and future prospects.","company_name":"BioStem Technologies, Inc.","ticker":"BSEM","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":25783,"accession_number":"0001193125-26-340271","item_number":"8.01","item_title":"Other Events","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioStem announced its uplisting from the OTC Basic Market to The Nasdaq Capital Market, effective August 7, 2026, with trading commencing under ticker \"BSEM.\" This is a material operational and strategic milestone that improves market visibility, liquidity, and access to capital for the company and its shareholders. While not a traditional M\u0026A transaction or governance change, the uplisting is a significant corporate event that would affect a reasonable investor's assessment of the registrant's market position and future prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:15:55.689303+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25783,"accession_number":"0001193125-26-340271","item_number":"8.01","item_title":"Other Events","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioStem announced its uplisting from the OTC Basic Market to The Nasdaq Capital Market, effective August 7, 2026, with trading commencing under ticker \"BSEM.\" This is a material operational and strategic milestone that improves market visibility, liquidity, and access to capital for the company and its shareholders. While not a traditional M\u0026A transaction or governance change, the uplisting is a significant corporate event that would affect a reasonable investor's assessment of the registrant's market position and future prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:15:55.689303+00:00","company_name":"BioStem Technologies, Inc.","ticker":"BSEM","filing_date":"2026-08-07"}]}